DAY 1 05.30(SAT)~31(SUN)
*Speaker Order has not been fixed yet.
TIME | Speech Title | Speaker |
Session 1 - Clinical Science | ||
13:00~ | Chairpersons | Zuguo Liu (China) Kazuo Tsubota (Japan) Hungwon Tchah (Korea) |
13:00~13:12 | Rethinking Dry Eye Treatment | Lingyi Liang (China) |
13:12~13:24 | A Real-World Study of 3% Diquas Sodium Eye Drops in Chinses Dry Eye Patients (The SPRING Study) | Yuqian Wang (China) |
13:24~13:36 | Long-term outcomes of diquafosol in dry eye management | Shizuka Koh (Japan) |
13:36~13:48 | Autonomic nerve activity in short tear film break-up time dry eye | Minako Kaido (Japan) |
13:48~14:00 | RF Treatments or Ocular Surface Diseases | Chul Young Choi (Korea) |
14:00~14:12 | Efficacy and safety of platelet‑rich plasma and autologous‑serum eye drops for dry eye in primary Sjögren’s syndrome | So-Hyang Chung (Korea) |
14:12~14:24 | Comparative Analysis of Intense Pulsed Light Therapy in Patients with Meibomian Gland Dysfunction, with and Without Glaucoma Medication | Ji Eun Lee (Korea) |
14:24~14:36 | Sponsor Session 1 | |
14:36~15:20 | Poster Session / Coffee Break | |
Session 2 - Educational Session | ||
15:20~ | Chairpersons | Ying Jie (China) Yuichi Hori (Japan) Kyoung Yul Seo (Korea) |
15:20~15:32 | Corneal Nerves and Dry Eye: Clinical Perspectives and Future Prospects | Jin Yuan (China) |
15:32~15:44 | Tear Film Dynamics in Health and Disease with a Focus on Mucins | Norihiko Yokoi (Japan) |
15:44~15:56 | Rethinking the Pathophysiology of Meibomian Mland Dysfunction | Jong Suk Song (Korea) |
15:56~16:08 | The Corneal Epithelial Barrier Function | Louis Tong (Singapore) |
Session 3 - Innovative Researcher's Session-1 | ||
16:08~ | Chairpersons | Wei Li (China) Norihiko Yokoi (Japan) Jong-Soo Lee (Korea) |
| 16:08~16:20 | Liquid Pulsation Therapy for Meibomian Gland Dysfunction Patients in China | Jiaxu Hong (China) |
| 16:20~16:32 | Stem Cell Protection for oGVHD Therapy | Kazuo Tsubota (Japan) |
| 16:32~16:48 | 1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea 2Laboratory of Ocular Regenerative Medicine and Immunology, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea | Mee Kum Kim (Korea) |
| 16:48~17:00 | Clinical Validation of a Novel MMP-9 measuring Device: Correlation with dry eye Parameters and tear film | Kyung-Sun Na (Korea) |
| 17:00~17:15 | Discussion | |
| Session 4 - KDES Session Co-Organized by KDES | ||
| 17:15~ | Chairpersons | Kyung Chul Yoon (Korea) In Chon Yu (Korea) |
| 17:15~17:27 | Comparison of Rebamipide and Diquafosol Eyedrops in Dry Eye Disease with Short Tear Break-Up Time. | Eun Chul Kim (Korea) |
| 17:27~17:39 | PM2.5 and Dry Eye Syndrome: Clinical Insights and Trends in Korea | Jinho Jeong (Korea) |
| 17:39~17:51 | Establishment of Mouse Meibomian Gland Organoids | Sun Woong Kim (Korea) |
| 17:51~18:03 | A Novel Interferometric Device for Measurement of Tear Film Lipid Layer Thickness in Mice | Ho Sik Hwang (Korea) |
| 18:08~18:12 | Discussion | |
DAY 2 05.31(SAT)
TIME | Speech Title | Speaker |
Session 5 - Basic Science | ||
08:30~ | Chairpersons | Wei Chen (China) Jun Shimazaki (Japan) Hyung Keun Lee (Korea) |
08:30~08:45 | Ocular Surface Involvements in the Development of Sjögren's Syndrome Associated Dry Eye in the IL14α Transgenic Mouse | Wei Li (China) |
08:45~09:00 | A Gatekeeper Sympathetic Control of Lacrimal Tear Secretion and Dry Eye Onset | Qingjun Zhou (China) |
09:00~09:15 | Exploring Possibilities of Functional Restoration of Tear Films Based on the Developmental Biology of the Lacrimal glands. | Masatoshi Hirayama (Japan) |
09:15~09:30 | Understanding the Regulation of Corneal Sensory Nerve Activities Aiming at Treatments for Dry Eye-Related Sensory Abnormalities | Takayoshi Masuoka (Japan) |
09:30~09:45 | Human Amniotic Epithelial Cell-derived Extracellular Vesicles as a cell-free therapyfor Dry Eye Disease | Hong Kyun Kim (Korea) |
09:45~10:00 | New Candidate Drugs for Dry Eye Disease: Induction of Fluid Secretion | Tae-im Kim (Korea) |
10:00~10:30 | Coffee Break | |
Session 6 - Innovative Researcher's Session-2 | ||
10:30~ | Chairpersons | Lingyi Liang (Chian) Shiro Amano (Japan) Joon Young Hyon (Korea) |
10:30~10:45 | Evaluation of Lacrimal Gland Ultrasound as a Diagnostic Tool for Primary Sjögren’sSyndrome-Related Dry Eye | Yun Feng (China) |
| 10:45~11:00 | Comprehensive Analysis of the Diversity and Pathogenesis of Dry Eye: a Digital Cohort Study | Takenori Inomata (Japan) |
| 11:00~11:15 | TBD | Jae Yong Kim (Korea) |
| 11:15~11:30 | Therapeutic Efficacy of Non-invasive Radiofrequency Treatment in Patients with Refractory Meibomian Gland Dysfunction: A Randomized Controlled Trial | Kendrick Co Shih (Hong Kong) |
| 11:30~11:45 | Role of Cisd2 in Corneal Epithelial Regeneration and DED | Chi-Chin Sun (Taiwan) |
11:45~12:00 | The Ocular Surface Microbiome: Roles, Dysbiosis, and Research Challenges | Vilavun Puangsricharern (Thailand) |
12:00~ | Best Poster Award and Closing | |
POSTER 05.30(SAT)~31(SUN)
Topic | Name |
Topical application of low concentration IL-2 enhances Treg’s function and plays anti-inflammatory roles in experimental dry eye | Baikai Ma |
Influence of dendritic cells on corneal nerve morphological analysis and clinical relevance in diabetes related dry eye | Hong Qi |
Improved Dry Eye Symptoms and Signs of Patients With Meibomian GlandDysfunction by a Dietary Supplement Abstract(maximum | Hua Wang |
Ocular Surface Changes in Patients with Psoriasis Vulgaris | Hui Zhang |
THE EFFICACY AND SAFETY OF 0.05% CYCLOSPORINE A (ZIRUN) OPHTHALMIC DROP FOR THE Sjögren's SYSDROME PATIENTS | Xiao ming Yan |
Targeting α7 Nicotinic Acetylcholine Receptor for Modulating the Neuroinflammation of Dry Eye Disease via Macrophage | Xujiao Zhou |
The Therapeutic Efficacy of Jīn Zhēn Eye Drop in Treating Dry Eye in a Chinese Population: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial | Yihan Guo |
Tear meniscal height in the Beijing Adult Dry Eye Cohort Study (ADEC) | Yiran Hao |
Development of a Multimodal Large Language Model for Early Warning and Diagnosis of Chronic Ocular GVHD | Shuwan Liu |
Association of Allergic Conjunctivitis with Anxiety and Depression in Children and Their Parents | Jing Li |
The role and influence of eyelid dynamics in moderate to severe dry eye with blepharospasm | Jingyi Wang |
CORRELATION BETWEEN SLEEP DISORDERS AND DRY EYE BASED ON WEARABLE SMART DEVICES | Ao Li |
Effect of Topical Emodin on Necroptosis and Inflammation in a Mouse Model of Experimental Dry Eye | Zhengri Li |
D-galactose-induced Aging Mouse Model Replicates Age-related Meibomian Gland Dysfunction | Zihao Liu |
Molecular mechanisms of angiogenesis in cultured media from adipose-derived stem cells during corneal wound healing | Yuichi Okumura |
Cost-Utility Analysis of 3% Diquafosol Sodium Eye Drops for Treatment of Dry Eye Disease | Ken Nagino |
Pre-Treatment Tear Film and Meibomian Gland Parameters as Predictors of Response to Intense Pulsed Light Therapy in MGD Patients | Reiko ARITA |
Changes in Dry Eye Disease Findings and Behavioral Patterns Before and After Using a Smartphone Application for Dry Eye Disease | Mako Okamoto |
MUC4 regulated intracellular network via mitochondrial signaling in corneal and conjunctival epithelial cells | Shu-Wen Chang |
Tear IL-6 level change and Response to Dry eye Treatment | Chia-Ying Tsai |
Optimizing Long-Term Topical Cyclosporine Treatment | Wan-Lin Wu |
AS-OCT Epithelial Mapping for Evaluating and Managing Ocular Surface Diseases: EK and RCE Insights | Wei Li Chen |
The Correlation among Ocular Surface and Lid-margin Related Outcomes, Work Productivity, and Daily Activity of Mild to Moderate Dye Eye Disease in Hong Kong | Kelvin Chong |
The effect based on meibography of vectored thermal pulsation, intense pulsed light and eyelid warm compress therapies for meibomian gland structure: a randomized controlled clinical trial | |
Diquafasol : The Role of Pre and Post Surgical Diquafosol Treatment in Cataract with Dry Eye | Rina La Distia Nora |
IDEQ: Validity and Reliability of the Indonesian Dry Eye Questionnaire and Its Correlation with Objective Clinical Signs in Patients | |
The caruncle is covered by a lipid layer and acts as a tear film reservoir during lateral eye movements | Timon Ax |
Beneficial Effect of Rebamipide Eye Drops on Blue Light-Induced Oxidative Damage in the Ocular Surface | JINGTING LIU |
Comparison of Therapeutic Effects of Rebamipide and Diquafosol on Ocular Surface Apoptotic Damage in a Murine Dry Eye Model | ENYING JIANG |
Effect of topical and oral Akkermansia muciniphila administration on dry eye disease in a scopolamineinduced murine model | Hun Lee |
Adverse effects of meteorological factors and air pollutants on dry eye disease: a hospital-based retrospective cohort study | Dong Hyun Kim |
Therapeutic Effects of Topical RCI001 on Environmental and Inflammation-related Dry eye mouse Models | |
Effect of Polydeoxyribonucleotide-Contact lens on Corneal Wound | Young Joo Shin |
Long-term Effects of Additional Topical Rebamipide 2% in Refractory Filamentary Keratitis | Sang Mok Lee |
A Comparative Study on the Clinical Effectiveness of Low-Concentration Cyclosporine Eye Drops in Patients with Dry Eye Syndrome | Jae Hyun Kim |
EGFR Inhibitor Induced Corneal Epithelial Defects in a Patient with Dry Eye | Ji Hoon Ban |
Efficacy of 2% Rebamipide Eye Drops for Dry Eye with Meibomian Gland Dysfunction | Myung Ho Cho |
Long-term treatment outcomes of pediatric blepharokeratoconjunctivitis without systemic antibiotics | Young Joon Choi |
Effects of microRNA-16-5p and microRNA-142-3p on inflammation and autophagy in vitro dry eye model on human corneal epithelium | Yu Jeong Kim |
Meibography Analysis of Young Age Patients with Blepharitis-Related Ocular Surface Diseases | Kyong Jin Cho |
Early myeloid cell infiltration and subset-specific macrophage responses in murine corneal nerve injury | Kyoung Woo Kim |
Impact of pterygium morphological profiles on dry eye parameters | Seung Hyeun Lee |
Evaluating Dry Eye Disease Subtypes using Tear Interferometry | Hyun min Ahn |